MobilEye Global Inc vs McKesson Corporation — how do they compare? MobilEye Global Inc trades at $8.9 (market cap $7.54B), while McKesson Corporation trades at $899.7 (market cap $105.14B). The key difference: McKesson Corporation is far larger — about 13.9× MobilEye Global Inc's market cap, and McKesson Corporation pays a 0.42% dividend while MobilEye Global Inc pays none. Which is the better fit depends on your goals.
| MBLY | MCK | |
|---|---|---|
Market Cap | $7.54B | $105.14B |
Sector | Technology | Health |
52-Week High | $15.54 | $995.69 |
52-Week Low | $6.56 | $659.01 |
Enterprise Value | $6.10B | $111.67B |
Dividend Yield | — | 0.42% |
Trailing returns across standard periods
Mobileye Global Inc. is a global leader in the development and deployment of Advanced Driver Assistance Systems (ADAS) and autonomous driving technologies. The company specializes in computer vision, machine learning, and data analysis to create sensing, mapping, and driving policy solutions. Mobileye's technology, including its EyeQ system-on-chips and its crowd-sourced mapping platform (REM), is integrated into vehicles worldwide, aiming to improve road safety and enable the future of autonomous mobility.
Read more on MBLY →McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →